Cancer Tumours Eradicated in Trial, But Skepticism and Questions Abound
Unprecedented trial results show a triple-action cancer jab, amivantamab, can eradicate entire tumours in patients whose disease has become resistant to other treatments. In an international trial, over a third of patients with advanced head and neck cancer experienced tumour shrinkage, with 15 seeing their tumours completely disappear. This innovative injection targets cancer in three ways, blocking growth-promoting proteins and activating the immune system, offering a significant advancement for patients with limited options.
John Q. Hosedrinker